# Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects

> **NCT01646489** · PHASE1 · COMPLETED · sponsor: **Santaris Pharma A/S** · enrollment: 5 (actual)

## Conditions studied

- Hepatitis C
- Chronic Hepatitis C

## Interventions

- **DRUG:** Miravirsen sodium
- **DRUG:** Telaprevir

## Key facts

- **NCT ID:** NCT01646489
- **Lead sponsor:** Santaris Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2012-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646489, "Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01646489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*